Kemira Oyj's Interim Report January-March 2015: Performance

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Kemira Oyj's Interim Report January-March 2015: Performance continued to improve

Kemira Oyj Stock Exchange Release April 24, 2015 at 1.30 pm (CET+1) This is a summary of the January - March 2015 Interim report. The complete January - March 2015 Interim report with tables is attached to this release and available at www.kemira.com/investors .

  • Revenue increased 4% to EUR 553.0 million (529.9) supported by favorable currency exchange rates. Revenues in local currencies, excluding acquisitions and divestments remained flat.
  • Operative EBITDA increased 15% to EUR 66.4 million (57.5) with a margin of 12.0% (10.9%).
  • Earnings per share decreased to EUR 0.16 (0.28). Comparable period included a capital gain of EUR 37 million related to the divestment of formic acid business.
  • Kemira maintains its outlook for 2015.

  Kemira's President and CEO Jari Rosendal:  "Kemira's year started according to plan. The revenue in the first quarter increased by 8%, excluding the impact of the divested formic acid business in Q1 2014. Operative EBITDA margin improved from 10.9% to 12.0% in Q1 2015. The strengthened U.S. dollar was the main reason for revenue growth. Nearly 40% of Kemira's revenue is either directly U.S. dollar-based or linked to the U.S dollar, like the Chinese renminbi. Growth in the Paper segment was solid in the first quarter, supported by favorable currency exchange rates and stable organic growth. Organic growth was driven by increased sales of new innovative solutions to our packaging board and paper customers, thus improving their operational efficiency as well as their end-product quality. In addition, pulp chemical deliveries to Montes del Plata pulp mill in Uruguay continued in line with the ramp up of the new mill. In the Oil & Mining segment, demand for our products for US shale operations has slowed down in Q1 due to significant reduction in the drilling and fracking activity in the region. Uncertainty around the US shale operations is expected to continue at least for the next couple of quarters. Strong U.S. dollar alleviates the situation to some extent but reaching topline growth in the Oil & Mining segment will be challenging in 2015. In the longer term, we remain optimistic about the growth in the business. I am pleased with the continued good progress in the Municipal & Industrial segment. The segment's revenue has stabilized after the restructuring period, and profitability has improved substantially, over 30% in the first quarter of 2015. The closure of AkzoNobel's paper chemical business acquisition is now expected to take place in Q2 2015, due to the pending approval from the competition authority in Ukraine. Our readiness to start the integration is very good. I consider Kemira to be well positioned to focus on growth with clear strategic objectives, customer-driven innovation, responsible business practices, and engaged and skilled professionals." KEY FIGURES AND RATIOS

EUR million  Jan-Mar 2015 Jan-Mar 2014 2014
Revenue 553.0 529.9 2,136.7
Operative EBITDA 66.4 57.5 252.9
Operative EBITDA, % 12.0 10.9 11.8
EBITDA 65.2 77.7 252.9
EBITDA, % 11.8 14.7 11.8
Operative EBIT 39.1 36.3 158.3
Operative EBIT, % 7.1 6.9 7.4
EBIT 37.8 54.3 152.6
EBIT, % 6.8 10.2 7.1
Share of profit or loss of associates 0.2 0.0 0.2
Financing income and expense -7.5 -5.3 -30.7
Profit before tax 30.5 49.0 122.1
Net profit 26.4 43.1 95.8
Earnings per share, EUR 0.16 0.28 0.59
Operative earnings per share 0.13 0.15 0.63
Capital employed* 1,466.2 1,460.0 1.427.7
Operative ROCE* 11.0 10.8 11.1
ROCE* 9.3 4.0 10.7
Capital expenditure 27.0 25.6 145.1
Cash flow after investing activities 16.0 130.3 75.2
Equity ratio, % at period-end 48 50 51
Gearing, % at period-end 49 30 42
Personnel at period-end 4,285 4,267 4,248

*12-month rolling average (ROCE, % based on the reported EBIT) Definitions of key figures are available at www.kemira.com > Investors > Financial information. Comparative 2014 figures are provided in parentheses for some financial results, where appropriate. Operative EBITDA, operative  EBIT, operative earnings per share and operative ROCE do not include non-recurring items. KEMIRA'S FINANCIAL TARGETS FOR 2017 AND OUTLOOK 2015 (UNCHANGED) Kemira will continue to focus on improving its profitability and operative cash flow. The company will also continue to invest in order to secure future growth to serve selected water intensive industries.

The company's financial targets for 2017 are:

  • revenue EUR 2.7 billion
  • Operative EBITDA-% of revenue 15%
  • gearing level <60%.

Kemira expects its capital expenditure-to-sales ratio, excluding acquisitions to increase in the next few years from the 2014 level of 6.3%. In addition, Kemira expects its medium-term operative tax rate to be in the range of 22%-25%. This rate excludes non-recurring items. The basis for growth is the expanding market for chemicals and Kemira's expertise that helps customers in water intensive industries to increase their water, energy and raw material efficiency. The need to increase operational efficiency in our customer industries creates opportunities for Kemira to develop new products and services for both current and new customers. Research and Development is a critical enabler of organic growth for Kemira, providing differentiation capabilities in its relevant markets. Kemira will invest in innovation, technical expertise, and competencies in its selected focus areas. Outlook for 2015 In 2015, Kemira will focus on profitable growth both organically and inorganically. Kemira's revenue in 2015 is expected to increase compared to 2014 and operative EBITDA in 2015 to remain approximately at the same level or to increase compared to 2014. The outlook excludes the impact of AkzoNobel paper chemical business (acquisition expected to close in the second quarter of 2015). At closing, AkzoNobel paper chemical business is expected to add revenue of more than EUR 200 million on an annualized basis. Helsinki, April 24, 2015

Kemira Oyj Board of Directors

FINANCIAL CALENDAR 2015 AND 2016 Interim Report January-June 2015                               July 22, 2015 Interim Report January-September 2015                      October 23, 2015 Financial Statements Bulletin 2015                             February 11, 2016 Interim Report January-March 2016                             April 26, 2016 Interim Report January-June 2016                               July 21, 2016 Interim Report January-September 2016                      October 25, 2016 Kemira Capital Markets Day will be held in Espoo R&D Center, Finland on September 17, 2015.

Press and analyst conference and conference call Kemira will arrange a press conference for analysts and the media starting at 2.30 pm (12.30 pm UK time) at Kemira House, Porkkalankatu 3, Helsinki. In the conference, Kemira's President and CEO Jari Rosendal and CFO Petri Castrén will present the results. The press conference will be held in English and will be webcasted at www.kemira.com/investors . The presentation material will be available around 2.00 pm and the webcast after the event at the above mentioned company web site. Conference call in connection to the press and analyst conference

You can also listen to the conference live over the phone and attend the Q&A session via a conference call. In order to participate in the call, please dial ten minutes before the conference begins: 

FI:     +358 9 817 10495 SE:    +46 8 566 42702 UK:   +44 20 31940552 US:   +1 855 7161597

No PIN code requested.

For more information, please contact Kemira Oyj Tero Huovinen, VP, Investor Relations +358 10 862 1980

Kemira is a global chemicals company serving customers in water-intensive industries. We provide expertise, application know-how and chemicals that improve our customers' water, energy and raw material efficiency. Our focus is on pulp & paper, oil & gas, mining and water treatment. In 2014, Kemira had annual revenue of EUR 2.1 billion and around 4,250 employees. Kemira shares are listed on the NASDAQ OMX Helsinki Ltd. www.kemira.com

Link to the release http://hugin.info/3008/R/1914000/684136.pdf

HUG#1914000

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lilly's Retatrutide Outshines Ozempic in Key Diabetes Trial

Updated Category News Views 24

Lilly's Breakthrough in Diabetes Treatment Eli Lilly's retatrutide is stirring up the diabetes treatment waters. The latest Phase 3 comparison to Ozempic's top dose reveals some surprising results. I'm not one to toss out kudos lightly, but this could be a genuine game-changer if things hold steady. A1C Reductions: A Close Look at the Numbers We’re staring down the...

Continue Reading
Samuel Oschin Air & Space Center Takes Flight This Fall

Updated Category News Views 98

The Grand Unveiling: November Highlights Look at this: space nerds, dreamers, and just about anybody with a heartbeat and a sense of wonder should circle November 13, 2026, like a kid with a candy store gift card. That's when the California Science Center throws open the doors to the Samuel Oschin Air and Space Center. You might as well slap a 'world's first' sticker on...

Continue Reading
Unicycive Faces Legal Heat: Shareholder Lawsuit Looms

Updated Category News Views 104

The Unicycive Landslide: What Went Down? Investors, buckle up. Unicycive Therapeutics Inc. (NASDAQ: UNCY) finds itself deep in the muck of a securities class action. Chief honchos, CEO Shalabh Gupta and CFO John Townsend, are taking the heat for allegedly controlling company disclosures that led shareholders to believe in non-existent progress with their third-party...

Continue Reading
Navigating Gas-to-AI Power: Challenges & Opportunities

Updated Category News Views 83

Natural Gas Abundance Meets Conversion Hurdles It’s a wild scene when you've got oodles of natural gas but struggle to get it into AI data centers. That’s the picture today: U.S. gas production hitting a high of 137 billion cubic feet daily, while converting that gas into practical energy is the real challenge. You see, the gas market is ready to rumble, ticking...

Continue Reading
Ameritas Hires Actuarial Veteran as VP in Strategic Move

Updated Category News Views 115

Shifting Gears at Ameritas: New VP Takes the Helm Well, chalk one up for Ameritas on this move. They've just brought on Ying Zhao as the new vice president of actuarial and financial strategy. It's a mouthful of a title, sure, but it's the role itself that's worth watching. Ameritas, for those not tracking, is a major player in the insurance and financial universe, doing...

Continue Reading
Replay Sports Cards Nets STAR Award for Innovation

Updated Category News Views 82

A New Era for Franchise Onboarding Just when you think the sports card world couldn't get any more niche, along comes Replay Sports Cards thumping its chest with some serious innovation. This Charlotte-based franchise just snagged the Franchise Innovation Award from Franchise Update Media. Yep, they're the only ones getting tips of the hat for the Most Innovative...

Continue Reading
Step into Fear: Dead by Daylight in Moreno Valley

Updated Category News Views 54

Immersive Horror in Moreno Valley Walking straight into the fog of your nightmares isn't for the faint-hearted, but that's the kind of thrill the Moreno Valley Museum & ArtSpace is serving up with its new Dead by Daylight Immersive Experience. Kicking off just in time for Halloween on October 30, this isn't your average stroll in a museum—it's a heart-pounding,...

Continue Reading
Armani/Casa Miami Earns Forbes Designation for Luxury

Updated Category News Views 34

Where Luxury Meets Thoughtfulness Residences by Armani/Casa Miami just nabbed a VERIFIED™ Luxury Residences badge from the Forbes Travel Guide folks. Now, you might be wondering why this is significant or if it's just another shiny tag in a world already glistening with luxury concepts. Well, there's a shift happening here, and it's got some meat to it. The folks...

Continue Reading
South Dakota's BEES Launch: Child Care Assistance Goes Live

Updated Category News Views 24

RedMane and South Dakota DSS: A New Milestone Talk about a leap into the digital age. South Dakota's Department of Social Services, teaming up with RedMane Technology, has just rolled out the Child Care Assistance Program on their BEES platform. That’s Benefits Eligibility and Enrollment System for those not keeping track. It represents a significant step in making life...

Continue Reading
QFIN Faces Lawsuit Over Broken Promises and Revenue Plunge

Updated Category News Views 48

Unmasking the Hype: QFIN's Pledge and Performance Investors, gather 'round because QFIN's latest uproar ain't pretty. The folks over at Qfin Holdings have found themselves in hot water, facing a class action lawsuit for allegedly pulling the wool over investors' eyes. Between March and August 2026, they promised a rock-solid ship braving China’s regulatory storm. Turns...

Continue Reading

Top 5 Most Recently Viewed Articles

BCMGlobal Takes Charge of NFSC's Loan Servicing Evolution

Updated Category News Views 197

BCMGlobal's New Role in Advancing NFSC BCMGlobal has been appointed to strategically manage the National Financing Support Services Company (NFSC), elevating it to a leading independent loan servicer. This initiative aims to promote excellence in the sector. Supporting Saudi Arabia's Financial Vision The NFSC, established with the backing of the Saudi Real Estate...

Continue Reading
Breakthrough MRD Data from Myriad Genetics at Cancer Conference

Updated Category News Views 201

Innovative Insights into MRD Testing Myriad Genetics, Inc. (NASDAQ: MYGN), a prominent name in molecular diagnostics and precision medicine, is set to unveil exciting new clinical findings related to their Precise MRD test at a significant annual meeting dedicated to cancer research. Presentation Highlights During the conference, Dr. Chad Tang from The University of Texas...

Continue Reading
SBM Offshore's Recent Share Buyback Program: Key Insights

Updated Category News Views 119

SBM Offshore's Share Buyback Program Overview SBM Offshore has recently reported on its significant share repurchase program, valued at EUR130 million (approximately US$140 million), covering transactions made from November 21, 2024, to November 27, 2024. This initiative underscores the company’s commitment to enhancing shareholder value through systematic buybacks. Key...

Continue Reading
Investigation into Akero Therapeutics by Berger Montague PC

Updated Category News Views 165

Akero Therapeutics Under Investigation by Berger Montague Berger Montague PC, a respected law firm, recently brought to attention an ongoing investigation into the practices of Akero Therapeutics, Inc. The investigation focuses on potential breaches of fiduciary duties and violations of federal securities laws by Akero’s Board of Directors, which has crucial...

Continue Reading
Nkarta's Upcoming Interactive Session: What to Expect?

Updated Category News Views 127

Nkarta to Engage with Investors in H.C. Wainwright Series Nkarta, Inc. (NASDAQ: NKTX), a pioneering clinical-stage biopharmaceutical firm dedicated to creating innovative engineered natural killer (NK) cell therapies, recently announced its notable role in the H.C. Wainwright "HCW@Home" Series. This virtual series will allow investors and interested parties to gain deeper...

Continue Reading